24.2 ± 19.1 U/L), and lower HMW adiponectin levels (4.2±0.7 vs. 5.0±0.5 μg/ml) than DM patients without NAFLD (p ≦0.001 for all values). Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.